Solid Biosciences Inc. (SLDB:NASDAQ) closed at $5.55 on October 14, 2026, down 4.73% on the day. The stock trades 51.6% below its 52-week high of $11.45 and 46.3% above its 52-week low of $3.79. Over the past year, it lost 6.6%. Solid Biosciences Inc. is part of the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)).
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -15.28% | -33.41% | -35.69% | -32.56% | -6.58% |
In 252 trading sessions since October 13, 2025, SLDB closed higher on 124 days (49%). Its best day was March 6, 2026 (+20.32%) and its worst was November 4, 2025 (-15.29%). The stock moved 10% or more in a single session 13 times.
Solid Biosciences Inc is a life science company engaged in developing therapies for Duchenne muscular dystrophy. Its product candidate, SGT-001, is a gene transfer under development to restore functional dystrophin protein expression in patients' muscles.
Find more stocks like SLDB with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.